Vimarsana
Biggest News Aggregation in the World

Repeat Dose Regimen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Repeat Dose Regimen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Repeat Dose Regimen Today - Breaking & Trending Today

Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update - Vimarsana News

Milestone Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Corporate Update

Published: August 10, 2023

NDA submission for etripamil in patients with PSVT expected in October 2023Data featured during oral session at Heart Rhythm 2023 Annual Meeting support the potential of etripamil in patients with... -Today at 07:37 am- MarketScreener

Source: marketscreener.com
Related Topics:
United StatesDavid PittsJoseph OlivetoProgram UpdatesCenters For DiseaseExchange CommissionUs Securities Exchange CommissionMilestone PharmaceuticalsCompany PhaseDrug AdministrationPrnewswire Milestone Pharmaceuticals IncMilestone Pharmaceuticals IncHeart RhythmNew Drug ApplicationChief Executive OfficerEtripamil Nasal SprayIntranasal Etripamil UsingRepeat Dose RegimenFeatured During Oral SessionMeeting Support PotentialConcept TrialWith Topline Data ExpectedFourth QuarterSupraventricular TachycardiaAtrial Fibrillation
Milestone Pharmaceuticals Announces Publication of Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with PSVT in The Lancet - Vimarsana News

Milestone Pharmaceuticals Announces Publication of Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with PSVT in The Lancet

Published: June 20, 2023

- Primary endpoint met, with 64.3% of patients who self-administered etripamil converting from supraventricular tachycardia to sinus rhythm within 30 minutes...

Source: prnewswire.com
Related Topics:
United StatesDavid PittsBruce StamblerDavid BharuchaKaplan MeierUs Securities Exchange CommissionPiedmont Heart InstituteMilestone Pharmaceuticals IncExchange CommissionMilestone PharmaceuticalsLead AuthorChief Medical OfficerIntranasal Etripamil UsingRepeat Dose RegimenNorth AmericaAbout Paroxysmal SupraventricularSupraventricular TachycardiaPrivate Securities Litigation Reform Act